Coronavirus

EU says decision on J&J COVID-19 vaccine booster dose ‘within weeks’

cde.news desk 22 November 2021, 14:30 · 1 min read

epa09065019 Exterior view of the pharmaceutical company Janssen in Leiden, The Netherlands, 10 March 2021. The European regulator, the European Medicines Agency (EMA), is expected to issue an decision soon on the vaccine against COVID-19 that has been developed by the Janssen pharmaceutical company. The Netherlands has ordered more than 11 million doses of the Leiden vaccine. The vaccine requires only one dose in order to immunise recipients against coronavirus. EPA-EFE/SEM VAN DER WAL

Nov 22 (Reuters) – The European Union’s drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson & Johnson and a decision could come “within weeks” under a speedy review.

The application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)

PHOTO – Exterior view of the pharmaceutical company Janssen in Leiden, The Netherlands. EPA-EFE/SEM VAN DER WAL